Tenax Therapeutics, Inc. (TENX)
NASDAQ: TENX · Real-Time Price · USD
4.700
-0.070 (-1.47%)
Nov 21, 2024, 11:16 AM EST - Market open
Tenax Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Cash & Equivalents | 98.31 | 9.79 | 2.12 | 5.58 | 6.25 | 4.91 | Upgrade
|
| Short-Term Investments | - | - | - | - | 0.46 | 0.49 | Upgrade
|
| Cash & Short-Term Investments | 98.31 | 9.79 | 2.12 | 5.58 | 6.71 | 5.4 | Upgrade
|
| Cash Growth | 782.41% | 361.09% | -61.97% | -16.82% | 24.32% | -58.02% | Upgrade
|
| Prepaid Expenses | 1.44 | 1.64 | 0.74 | 0.11 | 0.08 | 0.78 | Upgrade
|
| Other Current Assets | 0.03 | 0.25 | 0.35 | - | - | - | Upgrade
|
| Total Current Assets | 99.78 | 11.68 | 3.21 | 5.69 | 6.8 | 6.18 | Upgrade
|
| Property, Plant & Equipment | - | - | 0.19 | 0.29 | 0.06 | 0.18 | Upgrade
|
| Other Long-Term Assets | 0 | 0 | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Total Assets | 99.78 | 11.68 | 3.4 | 5.99 | 6.87 | 6.37 | Upgrade
|
| Accounts Payable | 1.58 | 2.07 | 0.45 | 0.86 | 0.76 | 1.66 | Upgrade
|
| Accrued Expenses | 0.98 | 1.01 | 0.66 | 0.6 | 1.18 | 0.76 | Upgrade
|
| Short-Term Debt | - | 0.5 | 0.62 | - | - | - | Upgrade
|
| Current Portion of Long-Term Debt | - | - | - | - | 0.12 | - | Upgrade
|
| Current Portion of Leases | - | - | 0.12 | 0.11 | 0.06 | 0.11 | Upgrade
|
| Total Current Liabilities | 2.56 | 3.59 | 1.85 | 1.56 | 2.12 | 2.53 | Upgrade
|
| Long-Term Debt | - | - | - | - | 0.12 | - | Upgrade
|
| Long-Term Leases | - | - | 0.06 | 0.18 | - | 0.06 | Upgrade
|
| Total Liabilities | 2.56 | 3.59 | 1.91 | 1.75 | 2.24 | 2.59 | Upgrade
|
| Common Stock | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | 405.81 | 305.35 | 291.03 | 282.74 | 250.64 | 239.94 | Upgrade
|
| Retained Earnings | -308.59 | -297.25 | -289.54 | -278.49 | -246.02 | -236.17 | Upgrade
|
| Comprehensive Income & Other | - | - | - | - | -0 | 0 | Upgrade
|
| Total Common Equity | 97.22 | 8.1 | 1.49 | 4.24 | 4.63 | 3.77 | Upgrade
|
| Shareholders' Equity | 97.22 | 8.1 | 1.49 | 4.24 | 4.63 | 3.77 | Upgrade
|
| Total Liabilities & Equity | 99.78 | 11.68 | 3.4 | 5.99 | 6.87 | 6.37 | Upgrade
|
| Total Debt | - | 0.5 | 0.81 | 0.29 | 0.31 | 0.17 | Upgrade
|
| Net Cash (Debt) | 98.31 | 9.29 | 1.32 | 5.29 | 6.41 | 5.23 | Upgrade
|
| Net Cash Growth | 796.45% | 606.13% | -75.14% | -17.40% | 22.57% | -59.35% | Upgrade
|
| Net Cash Per Share | 15.64 | 37.40 | 71.55 | 411.57 | - | - | Upgrade
|
| Filing Date Shares Outstanding | 3.41 | 1.96 | 0.35 | 0.02 | - | - | Upgrade
|
| Total Common Shares Outstanding | 3.41 | 0.3 | 0.03 | 0.02 | - | - | Upgrade
|
| Working Capital | 97.22 | 8.1 | 1.36 | 4.13 | 4.68 | 3.65 | Upgrade
|
| Book Value Per Share | 28.52 | 27.15 | 52.11 | 269.43 | - | - | Upgrade
|
| Tangible Book Value | 97.22 | 8.1 | 1.49 | 4.24 | 4.63 | 3.77 | Upgrade
|
| Tangible Book Value Per Share | 28.52 | 27.15 | 52.11 | 269.43 | - | - | Upgrade
|
| Machinery | - | - | - | - | - | 0.21 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.